Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia

Bone Marrow Transplantation, Published online: 07 November 2019; doi:10.1038/s41409-019-0742-7Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia
Source: Bone Marrow Transplantation - Category: Hematology Authors: Source Type: research